Details for New Drug Application (NDA): 018361
✉ Email this page to a colleague
NDA 018361 describes SEROPHENE, which is a drug marketed by Emd Serono and is included in one NDA. Additional details are available on the SEROPHENE profile page.
The generic ingredient in SEROPHENE is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
The generic ingredient in SEROPHENE is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
Summary for 018361
| Tradename: | SEROPHENE |
| Applicant: | Emd Serono |
| Ingredient: | clomiphene citrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018361
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Mar 22, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
